Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02329561Phase 1Completed
Phase 1, randomised, double-blind trial of tramadol in pain (2 arms), sponsored by Université de Montréal. Primary endpoint: Pharmacokinetic parameters (AUC 0-t, AUCinf, Cmax, tmax, t½, CL/F, Varea/F, Ae 0 48, Rmax, CLr) at 48 hours. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02329561.